This session is generously funded by Sanofi.
Hospital pharmacists play a critical role in vaccine stewardship, particularly in emergency settings where tetanus prophylaxis is routine. This session examines how Australia's recent diphtheria and pertussis outbreaks reveal an untapped opportunity: every tetanus shot for wound management already provides diphtheria protection through dT, but a simple formulary substitution to dTpa could add pertussis coverage without any workflow changes. Drawing on Queensland outbreak data and implementation research, this presentation provides hospital pharmacists with evidence-based rationale and practical strategies to optimise vaccine value in emergency departments.

This session is supported by industry funding. The presenting speaker is independent and is not employed by, or representing, the supporting company.